Kotak MF’s Nilesh Shah believes asset allocation is key despite record equity inflows
Nilesh Shah, MD of Kotak Mahindra AMC, says asset allocation should remain the cornerstone of investment strategy.
Uncategorized
Jupiter Wagons Q1 revenue, margins slide; net profit slumps 66% to ₹31 crore
EBITDA dived 56.3% to ₹59.9 crore in Q1FY26 over ₹137 crore last year. The EBITDA margin shrank to 13% versus 15.5% YoY. Shares of Jupiter Wagons Ltd ended at ₹329.45, down by ₹0.55 or 0.17%, on the BSE today (August…
Suzlon Energy Q1 Results: Strong operating performance despite higher tax expense, finance cost
In confirmation of a CNBC-TV18 newsbreak, Suzlon Energy also confirmed the resignation of Himanshu Mody, its Chief Financial Officer, who leaves after a four-year stint.
Gold, silver rally to continue, oil prices to fall in last quarter of 2025, says Peter McGuire
Peter McGuire, CEO of Trading.com, expects gold and silver prices to rally strongly in the second half of 2025, with gold potentially reaching $3,600 to $4,000 by year-end. He also sees a weakening US dollar and an expected rate cut…
Honasa Consumer Q1 Results | Net profit up 3% to ₹41 crore as revenue grows 7%
At the operating level, EBITDA dipped 1% to ₹45.7 crore in the first quarter of this fiscal over ₹46 crore in the corresponding period in the previous fiscal. Shares of Honasa Consumer Ltd ended at ₹269.90, up by ₹3.70 or…
Stock Split: Mrs. Bectors Foods to divide their equity shares; Check record date, other details
Mrs. Bectors Food Specialities approved a stock split in the ratio of 1:5, that is each equity share will be split into five equity shares. Record date for the split will be announced in due course.
Nykaa Q1 Results: Profit jumps 79% to ₹24 crore; margin sees 100 bps expansion
The board of Nykaa has also approved the acquisition of the remaining 40% equity stake in Nudge Wellness for ₹14.26 lakh. The transaction is expected to be completed by September 30, 2025.
Abbott India shares rise after company posts strong Q1 performance
Abbott India’s profit and revenue in the June quarter grew at similar pace, recording a 11.6% growth compared to last year. Besides, the company is slated to market MSD Pharmaceuticals’ oral anti-diabetes medications in India, including sitagliptin and its combination…
Explained — Five reasons why Astral shares saw their biggest single-day fall in three years
From its core business underperforming to inventory losses due to price volatility, here are five reasons why Astral shares fell the most since January 2022 on Tuesday.
BSE CEO on regulatory policy, expiry changes, Bankex volumes, and growth plans
BSE Managing Director and CEO Sundararaman Ramamurthy says any talk of shifting index expiry from weekly to fortnightly is speculative, with SEBI already clarifying its stance. He also outlined plans to expand participation, boost product offerings, and grow BSE’s cash…